0 Évaluations
ID

26002

Description

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT00434629

Lien

https://clinicaltrials.gov/show/NCT00434629

Mots-clés

Versions (2)
  1. 02/10/2017 02/10/2017 -
  2. 04/10/2017 04/10/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

4 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility B-Cell Lymphoma NCT00434629

    Anglais

    Eligibility B-Cell Lymphoma NCT00434629

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    cd20 positive b-cell lymphoma
    Description

    B-Cell Lymphoma CD20 antigen positive

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0079731
    UMLS CUI [1,2]
    C3888518
    confirmed relapsed/refractory disease following autologous transplant
    Description

    Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C2193200
    UMLS CUI [2]
    C0277556
    UMLS CUI [3]
    C1514815
    age ≤ 75 years
    Description

    Age

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    performance status 0 or 1
    Description

    Performance status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1518965
    creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
    Description

    Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0201976
    UMLS CUI [2]
    C2711451
    total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
    Description

    Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1278039
    UMLS CUI [2]
    C0201899
    UMLS CUI [3]
    C0201836
    UMLS CUI [4,1]
    C1705847
    UMLS CUI [4,2]
    C0005437
    UMLS CUI [4,3]
    C0678226
    UMLS CUI [4,4]
    C0017551
    no active cns disease
    Description

    CNS disorder Absent

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0007682
    UMLS CUI [1,2]
    C0332197
    no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
    Description

    Lymphoma involves bone marrow Undetectable Bone Marrow Examination

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1301440
    UMLS CUI [1,2]
    C3827727
    UMLS CUI [1,3]
    C0005957
    bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
    Description

    Bone marrow cellularity Percentage Bone Marrow Examination

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1561532
    UMLS CUI [1,2]
    C0439165
    UMLS CUI [1,3]
    C0005957
    availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
    Description

    Stem cell product Autologous CD34 positive Availability

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1706452
    UMLS CUI [1,2]
    C0439859
    UMLS CUI [1,3]
    C0882849
    UMLS CUI [1,4]
    C0470187
    cells/kg)
    Description

    ID.11

    Type de données

    boolean

    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    active infection
    Description

    Communicable Disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0009450
    pregnant woman are excluded from the study
    Description

    Pregnancy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0032961
    subjects not using contraceptives are excluded from the study
    Description

    Contraceptive methods Lacking

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0700589
    UMLS CUI [1,2]
    C0332268
    anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
    Description

    Absolute neutrophil count | Platelet Count measurement

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0948762
    UMLS CUI [2]
    C0032181
    life expectancy of ≤ 2 months
    Description

    Life Expectancy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
    Description

    Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0085101
    UMLS CUI [1,2]
    C0521124
    UMLS CUI [1,3]
    C0004561
    UMLS CUI [2]
    C0919274
    UMLS CUI [3]
    C0919272
    UMLS CUI [4,1]
    C0279694
    UMLS CUI [4,2]
    C0521124
    UMLS CUI [4,3]
    C0004561
    UMLS CUI [4,4]
    C0683607
    UMLS CUI [5,1]
    C0393022
    UMLS CUI [5,2]
    C0683607
    UMLS CUI [6,1]
    C1120776
    UMLS CUI [6,2]
    C0683607
    prior total body radiation therapy
    Description

    Total body radiation therapy

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0948732
    positive human anti-mouse antibody (hama) testing
    Description

    Human anti-mouse antibody test Positive

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C1868744
    UMLS CUI [1,2]
    C1514241
    Retour au début de la page

    Similar models

    Eligibility B-Cell Lymphoma NCT00434629

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    B-Cell Lymphoma CD20 antigen positive
    Item
    cd20 positive b-cell lymphoma
    boolean
    C0079731 (UMLS CUI [1,1])
    C3888518 (UMLS CUI [1,2])
    Autologous hematopoietic stem cell transplant | Recurrent disease | Refractory Disease
    Item
    confirmed relapsed/refractory disease following autologous transplant
    boolean
    C2193200 (UMLS CUI [1])
    C0277556 (UMLS CUI [2])
    C1514815 (UMLS CUI [3])
    Age
    Item
    age ≤ 75 years
    boolean
    C0001779 (UMLS CUI [1])
    Performance status
    Item
    performance status 0 or 1
    boolean
    C1518965 (UMLS CUI [1])
    Creatinine measurement, serum | Estimation of creatinine clearance by Cockcroft-Gault formula
    Item
    creatinine ≤ 1.5 or calculated creatinine clearance ≥ 60 ml/min
    boolean
    C0201976 (UMLS CUI [1])
    C2711451 (UMLS CUI [2])
    Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Bilirubin Due to Gilbert Disease
    Item
    total bilirubin, ast, and alt ≤ 1.5 x upper limit of normal (unless bilirubin due to gilbert's)
    boolean
    C1278039 (UMLS CUI [1])
    C0201899 (UMLS CUI [2])
    C0201836 (UMLS CUI [3])
    C1705847 (UMLS CUI [4,1])
    C0005437 (UMLS CUI [4,2])
    C0678226 (UMLS CUI [4,3])
    C0017551 (UMLS CUI [4,4])
    CNS disorder Absent
    Item
    no active cns disease
    boolean
    C0007682 (UMLS CUI [1,1])
    C0332197 (UMLS CUI [1,2])
    Lymphoma involves bone marrow Undetectable Bone Marrow Examination
    Item
    no detectable bone marrow involvement by lymphoma on histopathologic bone marrow examination
    boolean
    C1301440 (UMLS CUI [1,1])
    C3827727 (UMLS CUI [1,2])
    C0005957 (UMLS CUI [1,3])
    Bone marrow cellularity Percentage Bone Marrow Examination
    Item
    bone marrow cellularity ≥ 15% on histopathologic bone marrow examination
    boolean
    C1561532 (UMLS CUI [1,1])
    C0439165 (UMLS CUI [1,2])
    C0005957 (UMLS CUI [1,3])
    Stem cell product Autologous CD34 positive Availability
    Item
    availability of adequate stored autologous stem cell product (≥ 2 x 106 cd34+
    boolean
    C1706452 (UMLS CUI [1,1])
    C0439859 (UMLS CUI [1,2])
    C0882849 (UMLS CUI [1,3])
    C0470187 (UMLS CUI [1,4])
    ID.11
    Item
    cells/kg)
    boolean
    Item Group
    C0680251 (UMLS CUI)
    Communicable Disease
    Item
    active infection
    boolean
    C0009450 (UMLS CUI [1])
    Pregnancy
    Item
    pregnant woman are excluded from the study
    boolean
    C0032961 (UMLS CUI [1])
    Contraceptive methods Lacking
    Item
    subjects not using contraceptives are excluded from the study
    boolean
    C0700589 (UMLS CUI [1,1])
    C0332268 (UMLS CUI [1,2])
    Absolute neutrophil count | Platelet Count measurement
    Item
    anc ≤ 1,500/μl and/or platelet count ≤ 100,000/μl
    boolean
    C0948762 (UMLS CUI [1])
    C0032181 (UMLS CUI [2])
    Life Expectancy
    Item
    life expectancy of ≤ 2 months
    boolean
    C0023671 (UMLS CUI [1])
    Radioimmunotherapy Against B cells | Zevalin | Bexxar | Monoclonal Antibody Therapy Against B cells allowed | Rituximab allowed | Epratuzumab allowed
    Item
    prior anti-b-cell radioimmunotherapy (e.g., zevalin or bexxar) [patients who have received prior anti-b-cell monoclonal antibody therapy (e.g., rituximab or epratuzumab) will not be excluded.]
    boolean
    C0085101 (UMLS CUI [1,1])
    C0521124 (UMLS CUI [1,2])
    C0004561 (UMLS CUI [1,3])
    C0919274 (UMLS CUI [2])
    C0919272 (UMLS CUI [3])
    C0279694 (UMLS CUI [4,1])
    C0521124 (UMLS CUI [4,2])
    C0004561 (UMLS CUI [4,3])
    C0683607 (UMLS CUI [4,4])
    C0393022 (UMLS CUI [5,1])
    C0683607 (UMLS CUI [5,2])
    C1120776 (UMLS CUI [6,1])
    C0683607 (UMLS CUI [6,2])
    Total body radiation therapy
    Item
    prior total body radiation therapy
    boolean
    C0948732 (UMLS CUI [1])
    Human anti-mouse antibody test Positive
    Item
    positive human anti-mouse antibody (hama) testing
    boolean
    C1868744 (UMLS CUI [1,1])
    C1514241 (UMLS CUI [1,2])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial